NIH

July 21, 2017

Probing the genetics of autoimmunity

Vanderbilt researchers have found that non-coding regions of the genome appear to contribute to the risk of autoimmune diseases and may represent attractive therapeutic targets.

By Leigh MacMillan
July 20, 2017

Drivers of breast cancer metastasis

Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported.

By Leigh MacMillan
July 3, 2017

NOTCH1 role in heart development

The identification of a genetic culprit for hypoplastic left heart syndrome could lead to new treatments for the condition.

By VUMC News and Communications
June 30, 2017

Cytokine linked to blindness

A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

By Meredith Jackson
June 29, 2017

Team investigates antiviral that inhibits SARS, MERS

A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.

By Leigh MacMillan
June 29, 2017

Genetics of lung cancer survival

Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans.

By Sanjay Mishra
June 19, 2017

STINGing combination for cancer

A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.
By VUMC News and Communications
June 15, 2017

VUMC team’s discovery could lead to new diabetes treatment

By Bill Snyder
June 14, 2017

PET imaging to predict tumor response

A PET probe that detects the amino acid glutamine predicts whether tumors respond to certain targeted therapies in preclinical animal models.
By Leigh MacMillan
June 12, 2017

Repriming replication roadblocks

New findings shed light on how enzymes that replicate DNA skip over mutations that might cause cancer and restart DNA synthesis further away.
By Sanjay Mishra
June 9, 2017

Flip side of gut protection

Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease.
By Laura Daniel
June 8, 2017

VUMC lands renewal of Clinical and Translational Science Award

Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
By Bill Snyder
June 8, 2017

NIDDK renews Vanderbilt’s diabetes research grant

The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).
By Jill Clendening
1 … 45 46 47 48 49 … 101